Two stocks in Healthcare
Intuitive Surgical vs Johnson & Johnson: profit, growth, debt and price compared
Intuitive Surgical and Johnson & Johnson are each stronger on 2 of 5 figures: Intuitive Surgical on profit margin and sales growth; Johnson & Johnson on price for its expected profit and price trend.
Save both stocks to your watchlist and revisit their latest fundamentals.
| Intuitive SurgicalISRG | Johnson & JohnsonJNJ | |
|---|---|---|
| Net margin | Stronger: 25.5% | 16.2% |
| Revenue growth, past year | Stronger: +21.70% | +5.86% |
| Debt to equity | — | 54.8% |
| Forward P/E | 33.8× | Stronger: 23.5× |
| Dividend yield | — | 1.94% |
| Analysts | Buy · 30 | Buy · 22 |
| From its 200-day average | −2.6% | Stronger: +10.2% |
Share price over the past year
- Intuitive Surgical−23.0%
- Johnson & Johnson+36.3%
18 Nov 202518 Nov 2026
Intuitive Surgical or Johnson & Johnson: which is stronger?
- ISRG
Which is more profitable?
Intuitive Surgical keeps more of each sale as profit: 25.5% against 16.2%.
- ISRG
Which is growing its sales faster?
Intuitive Surgical is growing its sales faster: +21.70% over the past year, against +5.86%.
- JNJ
Which costs less for the profit it is expected to make?
Johnson & Johnson costs less for the profit it is expected to make: 23.5× its forward earnings, against 33.8×.
Which pays more in dividends?
Johnson & Johnson pays 1.94% a year in dividends for what a share costs, where Intuitive Surgical pays none.
Which do analysts rate higher?
Analysts rate both the same: Buy.
- JNJ
Which is in the stronger price trend?
Johnson & Johnson's price is in the stronger trend: 10.2% above its 200-day average, against 2.6% below.
What each company does
ISRGIntuitive Surgical
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
Reports results on 21 January 2027
JNJJohnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide.
Reports results on 26 January 2027
This comparison is just the starting point.
Discover opportunities, understand companies and compare investments in one place. See how StratDeck works
Keep researching
Where next
More comparisons
Free email
Up to speed in minutes, four times a week
Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.
Early access
Become a StratDeck founding user
Use StratDeck, tell us what's missing, and help decide what we build next.
100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.